Sign in Subscribe
Autoimmunity

Bifidobacterium's Role in Type 1 Diabetes: A Systematic Review

Strategic Insights

— 1 min read

Research into the development of type 1 diabetes has led to a new report discussing the potential role of Bifidobacterium in the disease's progression. According to a study published in the journal Endocrinology, Diabetes & Metabolism, alterations in the gut microbiome, including changes in Bifidobacterium abundance, are implicated in type 1 diabetes pathogenesis. A systematic review of 25 studies covering 4533 individuals, including those at risk of type 1 diabetes and those with established symptoms, found variability in Bifidobacterium abundance in type 1 diabetes patients. The study concluded that further research is needed to explore Bifidobacterium's role in type 1 diabetes progression and management.

Key Takeaways:

  • Type 1 diabetes frequently develops in childhood and is preceded by a non-symptomatic period of autoimmunity.
  • Alterations in the gut microbiome, including changes in Bifidobacterium abundance, are implicated in type 1 diabetes pathogenesis.
  • A systematic review of 25 studies covering 4533 individuals found variability in Bifidobacterium abundance in type 1 diabetes patients, with higher abundance found more often in at-risk asymptomatic individuals and lower abundance frequently found in those with established type 1 diabetes.
  • The study concluded that further research is needed to explore Bifidobacterium's role in type 1 diabetes progression and management.
  • The research was funded by the Juvenile Diabetes Research Foundation Australia, Leona M. and Harry B. Helmsley Charitable Trust, and National Health and Medical Research Council.
  • The study included individuals at risk of type 1 diabetes (pre-stage, stage 1 or 2 asymptomatic type 1 diabetes) and those with stage 3 symptomatic type 1 diabetes, while excluding type 2 diabetes, clinical trials, and animal studies.

Statistics:

  • 1120 articles were initially retrieved from the electronic search in MEDLINE, EMBASE, and Web of Science.
  • 25 papers met the inclusion criteria, covering 4533 individuals (842 cases with or at-risk of type 1 diabetes and 3691 healthy controls).
  • 69.4% of the studies found higher abundance of Bifidobacterium in at-risk asymptomatic individuals.
  • 57.1% of the studies found lower abundance of Bifidobacterium in those with established type 1 diabetes.

Sources:

  • NewsRx. Researchers from University of Notre Dame Report Details of New Studies and Findings in the Area of Type 1 Diabetes (Are Bifidobacterium Species Key Players in the Progression of Type 1 Diabetes? A Systematic Review). Clinical Trials Week. October 27, 2025; p 581.
  • Endocrinology, Diabetes & Metabolism. Are Bifidobacterium Species Key Players in the Progression of Type 1 Diabetes? A Systematic Review. 2025;8(6).

Read more